featured
Validation of Neutrophil-to-Lymphocyte Ratio in Patients With T1G3 Non–Muscle Invasive Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Genitourinary Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Validation of Neutrophil-to-Lymphocyte Ratio in a Multi-Institutional Cohort of Patients With T1G3 Non-Muscle-Invasive Bladder Cancer
Clin Genitourin Cancer 2018 Dec 01;16(6)445-452, MD Vartolomei, M Ferro, F Cantiello, G Lucarelli, S Di Stasi, R Hurle, G Guazzoni, GM Busetto, E De Berardinis, R Damiano, S Perdona, P Verze, R La Rocca, M Borghesi, R Schiavina, E Brunocilla, GL Almeida, P Bove, E Lima, G Grimaldi, R Autorino, N Crisan, AR Abu Farhan, M Battaglia, V Serretta, GI Russo, G Morgia, D Terracciano, G Musi, O de Cobelli, V Mirone, SF ShariatFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.